Retinyl Palmitate is a naturally-occurring phenyl analogue of retinol (vitamin A) with potential antineoplastic and chemopreventive activities. As the most common form of vitamin A taken for dietary supplementation, retinyl palmitate binds to and activates retinoid receptors, thereby inducing cell differentiation and decreasing cell proliferation. It is grouped under the following drug class(es): Retinoids and Vitamins. Its therapeutic use is listed as nutritional supplements and wound-healing agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Arovit, Optovit-A and Aquasol A (TN). Its PubChem CID is 5280531.
Retinol palmitate
| CAS No | 79-81-2 |
|---|---|
| Molecular Formula | C36H60O2 |
| Molecular Weight | 524.9 g/mol |
| Synonyms | [(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Retinyl Palmitate is a naturally-occurring phenyl analogue of retinol (vitamin A) with potential antineoplastic and chemopreventive activities.
The listed CAS number is 79-81-2.
The listed molecular formula is C36H60O2.
The listed molecular weight is 524.9 g/mol.
[(2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenyl] hexadecanoate.
The source lists Arovit, Optovit-A and Aquasol A (TN).